Corporations
23andMe defends genetic testing product
23andMe Chief Executive Officer Anne Wojcicki defended her company's genetic testing product and stands by the data on the accuracy of their results after the public warning letter issued by the US Food and Drug Administration.
TAKE TWO INTERACTIVE TO BUY 12.02 MLN OF ITS SHARES OWNED BY ICAHN GROUP
Take-Two Interactive Software, Inc. entered into a Purchase Agreement with Icahn Group. On November 26, 2013, Take-Two Interactive Software, Inc. entered into a Purchase Agreement with High River Limited Partnership, Icahn Partners LP, Icahn Partners Master Fund LP, Icahn Partners Master Fund II LP and Icahn Partners Master Fund III LP, pursuant to which the Company agreed to repurchase 12,020,744 shares of the Company's common stock owned by the Icahn Group, at a price per share of $16.
ZOOM TECHNOLOGIES INC. TO ACQUIRE BEIJING BAIFEN TONGLIAN INFORMATION & TECHNOLOGY CO., LTD.
ZOOM TECHNOLOGIES INC. TO ACQUIRE BEIJING BAIFEN TONGLIAN INFORMATION & TECHNOLOGY CO., LTD. Zoom Technologies, Inc. (Nasdaq:ZOOM) is a technology holding company focused on the mobile telecommunications and technology space.
CVS Caremark to acquire Coram infusion for USD2.1 billion from Apria Healthcare Group
CVS Caremark announced on Wednesday that it will be consolidating the Coram infusion business once the acquisition deal with Apria Healthcare Group will be finalized.